AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21649935 — intervention group
Group type: COMPARATOR
Intervention: Referral to Emergency Department (ED) via ambulance transfer
Number of subjects: 0
Study 19344914 — intervention group
Group type: EXPERIMENTAL
Intervention: Montgomery Asberg Depression Rating Scale (MADRS)
Number of subjects: 0
Study 19344914 — intervention group
Group type: COMPARATOR
Intervention: Hamilton Depression Rating Scale (HAMD)
Number of subjects: 0
Study 19344914 — intervention group
Group type: COMPARATOR
Intervention: Subscales of HAMD
Number of subjects: 0
Study 16298441 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic hydration
Number of subjects: 1383
Study 16298441 — intervention group
Group type: COMPARATOR
Intervention: Half‐isotonic hydration
Number of subjects: 1383
Study 16298441 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 1383
Study 15167082 — intervention group
Group type: EXPERIMENTAL
Intervention: CWD‐A (Adolescent Coping With Depression course)
Number of subjects: 93
Study 15167082 — intervention group
Group type: COMPARATOR
Intervention: Life skills/tutoring control
Number of subjects: 93
Study 15167082 — intervention group
Group type: EXPERIMENTAL
Intervention: CWD‐A
Number of subjects: 93
Study 10872953 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone probing measurement
Number of subjects: 28
Study 10872953 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographic bone level (RBL)
Number of subjects: 28
Study 10872953 — intervention group
Group type: EXPERIMENTAL
Intervention: Probing depth
Number of subjects: 28
Study 9109757 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial good visual acuity (20/40 or better)
Number of subjects: 725
Study 9109757 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial intermediate visual acuity (20/50-20/200)
Number of subjects: 725
Study 9109757 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial poor visual acuity (< 20/200)
Number of subjects: 725
Study 9109757 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes with perfusion
Number of subjects: 725
Study 9109757 — intervention group
Group type: EXPERIMENTAL
Intervention: Iris neovascularization (INV) or angle neovascularization (ANV)
Number of subjects: 725
Study 9109757 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes initially categorized as nonperfused or indeterminate
Number of subjects: 725
Study 9109757 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes initially categorized as perfused
Number of subjects: 725
Study 9109757 — intervention group
Group type: EXPERIMENTAL
Intervention: Neovascular glaucoma
Number of subjects: 725
Study 8468437 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide (150 mg three times daily, adjusted to 300-600 mg/day)
Number of subjects: 122
Study 8468437 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (20 mg/day, adjusted to 20-40 mg/day)
Number of subjects: 122
Study 8468437 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 122
Study 8468437 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide
Number of subjects: 122
Study 2870014 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg betaxolol
Number of subjects: 10
Study 2870014 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg nadolol
Number of subjects: 10
Study 2870014 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2466712 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadexomer iodine
Number of subjects: 67
Study 2466712 — intervention group
Group type: COMPARATOR
Intervention: Standard dressings
Number of subjects: 67
Study 31262573 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of tramadol 1 mg/kg (group T)
Number of subjects: 304
Study 31262573 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (group C)
Number of subjects: 304
Study 28341982 — intervention group
Group type: EXPERIMENTAL
Intervention: Short focused cardiac ultrasound scan using a pocket-sized Vscan
Number of subjects: 40
Study 28341982 — intervention group
Group type: COMPARATOR
Intervention: No scan
Number of subjects: 40
Study 25540298 — intervention group
Group type: EXPERIMENTAL
Intervention: Graft volume and median signal intensity (SI) measured via MRI
Number of subjects: 0
Study 23468056 — intervention group
Group type: COMPARATOR
Intervention: artemether-lumefantrine (AL)
Number of subjects: 298
Study 23468056 — intervention group
Group type: EXPERIMENTAL
Intervention: dihydroartemisinin-piperaquine (DP)
Number of subjects: 298
Study 21343767 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipelle
Number of subjects: 0
Study 21343767 — intervention group
Group type: COMPARATOR
Intervention: Explora
Number of subjects: 0
Study 19231778 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft Liner and DuoDERM protection
Number of subjects: 18
Study 19231778 — intervention group
Group type: COMPARATOR
Intervention: No cushioning protection
Number of subjects: 18
Study 16822102 — intervention group
Group type: EXPERIMENTAL
Intervention: Online family problem solving therapy (FPS)
Number of subjects: 40
Study 16822102 — intervention group
Group type: COMPARATOR
Intervention: Internet resources (IRC)
Number of subjects: 40
Study 12571159 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol valerate 2 mg tablet
Number of subjects: 36
Study 10685353 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotion-focused therapy (EFT) for couples, 8 weekly sessions
Number of subjects: 40
Study 10685353 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control group), 8-week waiting period
Number of subjects: 40
Study 9117452 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrin sulphate (D2S) gel
Number of subjects: 36
Study 9117452 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 8174967 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐33 (0.25 IDU.kg‐1.h‐1) during 8 mmol/l hyperglycaemia
Number of subjects: 6
Study 8174967 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐33 (0.5 IDU.kg‐1.h‐1) during 8 mmol/l hyperglycaemia
Number of subjects: 6
Study 8174967 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐33 (0.25 IDU.kg‐1.h‐1) during 15 mmol/l hyperglycaemia
Number of subjects: 6
Study 8174967 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐33 (0.5 IDU.kg‐1.h‐1) during 15 mmol/l hyperglycaemia
Number of subjects: 6
Study 8174967 — intervention group
Group type: EXPERIMENTAL
Intervention: CCK‐33 (1.0 IDU.kg‐1.h‐1) during 15 mmol/l hyperglycaemia
Number of subjects: 6
Study 8174967 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal plasma PP concentrations during hyperglycaemia
Number of subjects: 6
Study 8174967 — intervention group
Group type: EXPERIMENTAL
Intervention: PP secretion in response to CCK‐33 during hyperglycaemia
Number of subjects: 6
Study 3956116 — intervention group
Group type: EXPERIMENTAL
Intervention: Gold therapy (Auromyose) in the same dosage schedule as before the study
Number of subjects: 24
Study 3956116 — intervention group
Group type: COMPARATOR
Intervention: Placebo (gold in a suspension diluted 1/100)
Number of subjects: 24
Study 30850143 — intervention group
Group type: EXPERIMENTAL
Intervention: Baduanjin exercise 3 days/week at hospital and 4 days/week at home for 6 months
Number of subjects: 86
Study 30850143 — intervention group
Group type: COMPARATOR
Intervention: Control group maintaining original physical activity
Number of subjects: 86
Study 29208618 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (20 mg two times per day)
Number of subjects: 30
Study 29208618 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical to methylphenidate)
Number of subjects: 30
Study 25398288 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-extremity amputation (LEA) group
Number of subjects: 55
Study 25398288 — intervention group
Group type: COMPARATOR
Intervention: Non-LEA group
Number of subjects: 55
Study 25398288 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analyses
Number of subjects: 55
Study 24576168 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast prehydration regimen
Number of subjects: 0
Study 24576168 — intervention group
Group type: COMPARATOR
Intervention: Standard prehydration regimen
Number of subjects: 0
Study 23488361 — intervention group
Group type: EXPERIMENTAL
Intervention: ACNP-led care
Number of subjects: 103
Study 23488361 — intervention group
Group type: COMPARATOR
Intervention: Hospitalist-led care
Number of subjects: 103
Study 19635023 — intervention group
Group type: EXPERIMENTAL
Intervention: Daptomycin
Number of subjects: 89
Study 19635023 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin-gentamicin
Number of subjects: 89
Study 17577462 — intervention group
Group type: EXPERIMENTAL
Intervention: Manidipine 10 mg/d
Number of subjects: 40
Study 17577462 — intervention group
Group type: EXPERIMENTAL
Intervention: Delapril 30 mg/d
Number of subjects: 40
Study 17577462 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Manidipine and Delapril
Number of subjects: 40
Study 15273564 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity model training (live rat vas deferens; n = 21)
Number of subjects: 50
Study 15273564 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fidelity model training (silicone tubing; n = 19)
Number of subjects: 50
Study 15273564 — intervention group
Group type: COMPARATOR
Intervention: Didactic training alone (n = 10)
Number of subjects: 50
Study 15273564 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity model training
Number of subjects: 50
Study 15273564 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fidelity model training
Number of subjects: 50
Study 15273564 — intervention group
Group type: COMPARATOR
Intervention: Didactic training
Number of subjects: 50
Study 12542882 — intervention group
Group type: EXPERIMENTAL
Intervention: Transurethral vapor resection of the prostate (TUVRP) using the vapor resection loop.
Number of subjects: 100
Study 12542882 — intervention group
Group type: COMPARATOR
Intervention: Standard wire loop TURP.
Number of subjects: 100
Study 12542882 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions were assessed for efficacy using IPSS, Q(max), and residual urine volume.
Number of subjects: 100
Study 12542882 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions were evaluated for complications.
Number of subjects: 100
Study 9588408 — intervention group
Group type: EXPERIMENTAL
Intervention: RheothRx (poloxamer 188)
Number of subjects: 196
Study 7832301 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg intranasal midazolam
Number of subjects: 88
Study 7832301 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg intranasal midazolam
Number of subjects: 88
Study 7832301 — intervention group
Group type: COMPARATOR
Intervention: Intranasal saline drops (placebo)
Number of subjects: 88
Study 2212409 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular use of aqueous beclomethasone diproprionate nasal spray (200 micrograms, twice daily)
Number of subjects: 60
Study 2212409 — intervention group
Group type: COMPARATOR
Intervention: As required use of aqueous beclomethasone diproprionate nasal spray (100 micrograms, as needed, up to 400 micrograms daily)
Number of subjects: 60
Study 2212409 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular use of aqueous beclomethasone diproprionate nasal spray
Number of subjects: 60
Study 2212409 — intervention group
Group type: COMPARATOR
Intervention: As required use of aqueous beclomethasone diproprionate nasal spray
Number of subjects: 60
Study 112457 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium escinate
Number of subjects: 142
Study 112457 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid therapy
Number of subjects: 142
Study 31301293 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (FOURIER trial)
Number of subjects: 0
Study 31301293 — intervention group
Group type: EXPERIMENTAL
Intervention: Bococizumab (SPIRE-1 and SPIRE-2 trials)
Number of subjects: 0
Study 31301293 — intervention group
Group type: EXPERIMENTAL
Intervention: Alirocumab (ODYSSEY OUTCOMES trial)
Number of subjects: 0
Study 31301293 — intervention group
Group type: COMPARATOR
Intervention: Meta-regression prediction
Number of subjects: 0
Study 30572069 — intervention group
Group type: EXPERIMENTAL
Intervention: Smaller facemask (35 mm or 42 mm)
Number of subjects: 131
Study 30572069 — intervention group
Group type: COMPARATOR
Intervention: Standard facemask (50 mm)
Number of subjects: 131
Study 27789268 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day antibiotic regimen (group A)
Number of subjects: 171
Study 27789268 — intervention group
Group type: COMPARATOR
Intervention: 1-day antibiotic regimen (group B)
Number of subjects: 171
Study 25329681 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol/Fluticasone Propionate Combination (SFC) 50/100 µg once daily for 12 weeks
Number of subjects: 43
Study 25329681 — intervention group
Group type: COMPARATOR
Intervention: Inhaled Salmeterol (SAL) 50 µg twice daily for 12 weeks
Number of subjects: 43
Study 25329681 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of both treatments after 12 weeks
Number of subjects: 43
Study 22092536 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (APAP 1 g) + Saline (placebo)
Number of subjects: 12
Study 22092536 — intervention group
Group type: COMPARATOR
Intervention: Placebo (pl) + Saline (placebo)
Number of subjects: 12
Study 22092536 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (APAP 1 g) + Naloxone (Nal 8 mg)
Number of subjects: 12
Study 22092536 — intervention group
Group type: COMPARATOR
Intervention: Placebo (pl) + Naloxone (Nal 8 mg)
Number of subjects: 12
Study 21854752 — intervention group
Group type: EXPERIMENTAL
Intervention: Clodronate (CLO) treatment
Number of subjects: 0
Study 21854752 — intervention group
Group type: COMPARATOR
Intervention: PBS treatment
Number of subjects: 0
Study 19473513 — intervention group
Group type: EXPERIMENTAL
Intervention: PACAM nutrition supplement
Number of subjects: 0
Study 19473513 — intervention group
Group type: EXPERIMENTAL
Intervention: Specially designed exercise programme
Number of subjects: 0
Study 19473513 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 17762955 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with low insufflation pressure (7‐9 mmHg)
Number of subjects: 60
Study 17762955 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with high insufflation pressure (13‐15 mmHg)
Number of subjects: 60
Study 17762955 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia plus epidural analgesia with low insufflation pressure
Number of subjects: 60
Study 17762955 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia plus epidural analgesia with high insufflation pressure
Number of subjects: 60
Study 15018027 — intervention group
Group type: EXPERIMENTAL
Intervention: Worksite physical activity counseling (N = 131)
Number of subjects: 299
Study 15018027 — intervention group
Group type: COMPARATOR
Intervention: Control group (N = 168)
Number of subjects: 299
Study 11549415 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine colostrum whey
Number of subjects: 18
Study 11549415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 9931797 — intervention group
Group type: EXPERIMENTAL
Intervention: IMPACT (Test)
Number of subjects: 29
Study 9931797 — intervention group
Group type: COMPARATOR
Intervention: isonitrogenous isocaloric diet (Control)
Number of subjects: 29
Study 7539635 — intervention group
Group type: EXPERIMENTAL
Intervention: FK 506 (tacrolimus) at a starting dose of 0.15 mg/kg/day for 12 months
Number of subjects: 19
Study 3200556 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine
Number of subjects: 47
Study 3200556 — intervention group
Group type: COMPARATOR
Intervention: Meperidine
Number of subjects: 47
Study 3200556 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 47
Study 31992077 — intervention group
Group type: EXPERIMENTAL
Intervention: Shokti+, a nutritionally fortified yogurt
Number of subjects: 1000
Study 31992077 — intervention group
Group type: COMPARATOR
Intervention: Market price of Shokti+
Number of subjects: 1000
Study 30654054 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ tree SLIT-tablet
Number of subjects: 634
Study 30654054 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 634
Study 28238587 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D full-volume color Doppler transthoracic echocardiography (FVCD)
Number of subjects: 152
Study 28238587 — intervention group
Group type: COMPARATOR
Intervention: 2D proximal isovelocity surface area (PISA)
Number of subjects: 152
Study 28238587 — intervention group
Group type: COMPARATOR
Intervention: 2D volumetric method (VM)
Number of subjects: 152
Study 26220564 — intervention group
Group type: EXPERIMENTAL
Intervention: Bite Back positive psychology program
Number of subjects: 0
Study 26220564 — intervention group
Group type: COMPARATOR
Intervention: Control condition (non-psychology entertainment websites)
Number of subjects: 0
Study 23414459 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest method for detecting response shift in quality of life (QoL)
Number of subjects: 524
Study 21496517 — intervention group
Group type: EXPERIMENTAL
Intervention: editing‐out‐the‐negative skills training
Number of subjects: 100
Study 21496517 — intervention group
Group type: EXPERIMENTAL
Intervention: accepting influence skills training
Number of subjects: 100
Study 21496517 — intervention group
Group type: COMPARATOR
Intervention: time‐out
Number of subjects: 100
Study 21496517 — intervention group
Group type: EXPERIMENTAL
Intervention: skills training (both editing-out-the-negative and accepting influence)
Number of subjects: 100
Study 18563062 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol-dependent individuals (ADs)
Number of subjects: 34
Study 18563062 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress and alcohol cue exposure
Number of subjects: 34
Study 18563062 — intervention group
Group type: COMPARATOR
Intervention: Social drinkers (SDs)
Number of subjects: 34
Study 17020076 — intervention group
Group type: EXPERIMENTAL
Intervention: scale up on velocity with no instruction
Number of subjects: 60
Study 17020076 — intervention group
Group type: COMPARATOR
Intervention: maintain constant velocity with no instruction
Number of subjects: 60
Study 17020076 — intervention group
Group type: EXPERIMENTAL
Intervention: maintain constant velocity with instruction
Number of subjects: 60
Study 17020076 — intervention group
Group type: EXPERIMENTAL
Intervention: scale up on velocity with instruction
Number of subjects: 60
Study 15527479 — intervention group
Group type: EXPERIMENTAL
Intervention: Out-of-home pre-school day care
Number of subjects: 120
Study 15527479 — intervention group
Group type: EXPERIMENTAL
Intervention: In-depth interviews with mothers
Number of subjects: 120
Study 11117247 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4% glycerol
Number of subjects: 10
Study 9308793 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase type IV
Number of subjects: 20
Study 9308793 — intervention group
Group type: COMPARATOR
Intervention: Collagenase type IA
Number of subjects: 20
Study 9308793 — intervention group
Group type: COMPARATOR
Intervention: Collagenase type IA supplemented with elastase
Number of subjects: 20
Study 9308793 — intervention group
Group type: COMPARATOR
Intervention: Collagenase type IV supplemented with elastase
Number of subjects: 20
Study 7854920 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g i.v. acetazolamide
Number of subjects: 29
Study 7854920 — intervention group
Group type: COMPARATOR
Intervention: rCBF SPECT and TCD
Number of subjects: 29
Study 2671560 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months supervised daily RMP 600 mg, ETH 500 mg and DDS 100 mg or CLO 100 mg followed by 6 months unsupervised daily DDS 100 mg or CLO 100 mg with ETH 500 mg added or not
Number of subjects: 289
Study 2671560 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months supervised daily RMP 600 mg, ETH 500 mg and DDS 100 mg or CLO 100 mg
Number of subjects: 289
Study 2671560 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 months unsupervised daily DDS 100 mg or CLO 100 mg with ETH 500 mg added or not
Number of subjects: 289
Study 920841 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg/day of disulfiram
Number of subjects: 81
Study 920841 — intervention group
Group type: COMPARATOR
Intervention: 250 mg/day of disulfiram
Number of subjects: 81
Study 920841 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 81
Study 31351548 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Respiratory Muscle Training
Number of subjects: 0
Study 31351548 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 28107822 — intervention group
Group type: EXPERIMENTAL
Intervention: Training course (1.5 hours)
Number of subjects: 286
Study 26818683 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based stress management intervention (iSMI)
Number of subjects: 264
Study 23891363 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibric acid (FA) 45 mg + Rosuvastatin (R) 5 mg for 8 weeks, then 10 mg for 8 additional weeks
Number of subjects: 0
Study 23891363 — intervention group
Group type: COMPARATOR
Intervention: Rosuvastatin (R) 5 mg for 8 weeks, then 10 mg for 8 additional weeks
Number of subjects: 0
Study 21606149 — intervention group
Group type: EXPERIMENTAL
Intervention: EMONO (50% nitrous oxide and 50% oxygen)
Number of subjects: 100
Study 21606149 — intervention group
Group type: COMPARATOR
Intervention: Placebo (50% nitrogen and 50% oxygen)
Number of subjects: 100
Study 19484433 — intervention group
Group type: EXPERIMENTAL
Intervention: IDD Therapy (Intervertebral Differential Dynamics Therapy) with traction weight systematically increased until 50% of a person's body weight plus 4.45 kg (10 lb) was reached.
Number of subjects: 60
Study 19484433 — intervention group
Group type: COMPARATOR
Intervention: SHAM group with a non‐therapeutic traction weight of 4.45 kg in all sessions.
Number of subjects: 60
Study 19484433 — intervention group
Group type: EXPERIMENTAL
Intervention: IDD Therapy and SHAM group (both groups received standard conservative therapeutic care and 20 sessions).
Number of subjects: 60
Study 16624438 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin sensitivity formula proposed by McAuley
Number of subjects: 72
Study 16624438 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 72
Study 14560062 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine 24 mg/day
Number of subjects: 285
Study 14560062 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 285